• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Transfusion risks: importance of blood surveillance].

作者信息

Salamon R, Lawson-Ayayi S, Salmi L R

机构信息

Département d'Epidémiologie, Biostatistiques et Informatique Médicale, Université de Bordeaux II.

出版信息

Transfus Clin Biol. 1994;1(5):373-8. doi: 10.1016/s1246-7820(06)80019-4.

DOI:10.1016/s1246-7820(06)80019-4
PMID:7812464
Abstract

Transfusion risks result from the transfusion chain complexity and are due to human errors and limits of screening technics. Causes, mechanisms and manifestations of the main risks are mostly well known. Transfusion risks can be related to the donor, the blood donation or the transfusion act. The mechanisms are immediate or delayed. Environment can be a favorable factor. In France, rates of transfusion risks and the part of risk attributable to the environment are not known with accuracy because of the absence of a mandatory reporting system. The assessment of the existing prevention policies, essential for envisaging new actions, lacks rigour. The setting of means assessment and follow-up of transfusion safety as it was mentioned by the Comity of transfusion safety follow-up (L. Degos, A. Goudeau, R. Salamon) in november 1991, and in the law no. 93-5 of january 4, 1993 would allow the improvement of epidemiologic features of blood donation, blood use and transfusion risks.

摘要

相似文献

1
[Transfusion risks: importance of blood surveillance].
Transfus Clin Biol. 1994;1(5):373-8. doi: 10.1016/s1246-7820(06)80019-4.
2
[Failure mechanisms in the transfusion process. Importance of anticipatory operational safety analysis].[输血过程中的故障机制。预期操作安全性分析的重要性]
Transfus Clin Biol. 1994;1(5):379-86. doi: 10.1016/s1246-7820(06)80020-0.
3
Improving safety of blood transfusion in developing countries.提高发展中国家输血的安全性。
Vox Sang. 1994;67 Suppl 3:61-6. doi: 10.1111/j.1423-0410.1994.tb04545.x.
4
[Preventing deficiencies in the transfusion process].[预防输血过程中的缺陷]
Transfus Clin Biol. 1994;1(6):455-65. doi: 10.1016/s1246-7820(06)80030-3.
5
The French haemovigilance system.法国血液警戒系统。
Vox Sang. 1999;77(2):77-81. doi: 10.1159/000031080.
6
Safe blood transfusion practices.
Indian J Pediatr. 2001 Feb;68(2):127-31. doi: 10.1007/BF02722029.
7
Is there a limit to the normality of blood products?血液制品的正常标准有上限吗?
Hematol J. 2000;1(5):291. doi: 10.1038/sj.thj.6200059.
8
Advances in pretransfusion infectious disease testing: ensuring the safety of transfusion therapy.输血前传染病检测的进展:确保输血治疗的安全性。
Clin Lab Med. 2002 Jun;22(2):475-90. doi: 10.1016/s0272-2712(01)00007-5.
9
Preparing for inspection: managing regulations and practices surrounding donors with positive infectious disease testing.准备检查:管理围绕传染病检测呈阳性的捐赠者的法规和做法。
J Clin Apher. 2008;23(6):191-5. doi: 10.1002/jca.20177.
10
[Blood monitoring at the dawn of the 21st century].[21世纪初的血液监测]
Presse Med. 2000;29(19):1066-71.